Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Jones James Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Small acquisition of 65 shares @ $1.68, valued at $109.2
Small acquisition of 65 shares @ $1.65, valued at $107.3
Small acquisition of 65 shares @ $1.68, valued at $109.2
Small acquisition of 65 shares @ $1.68, valued at $109.2
Small acquisition of 65 shares @ $1.72, valued at $111.8
Small acquisition of 65 shares @ $1.76, valued at $114.4
Small acquisition of 65 shares @ $1.83, valued at $119
Small acquisition of 65 shares @ $1.84, valued at $119.6
Small acquisition of 23 shares @ $1.82, valued at $41.9
Small acquisition of 55 shares @ $2.03, valued at $111.7
Small acquisition of 55 shares @ $2.12, valued at $116.6
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Bought 31 shares @ $2.57, valued at $79.7
Bought 31 shares @ $2.52, valued at $78.1
Bought 31 shares @ $2.51, valued at $77.8
Bought 31 shares @ $2.61, valued at $80.9
Bought 31 shares @ $2.54, valued at $78.7
Bought 31 shares @ $2.61, valued at $80.9
Bought 31 shares @ $2.58, valued at $80
Bought 31 shares @ $2.65, valued at $82.2
Bought 31 shares @ $2.66, valued at $82.5
Bought 31 shares @ $2.53, valued at $78.4
Bought 31 shares @ $2.48, valued at $76.9
09/30/2022 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Bought 32 shares @ $2.35, valued at $75.2
Bought 32 shares @ $2.31, valued at $73.9
Bought 32 shares @ $2.23, valued at $71.4
Bought 32 shares @ $2.35, valued at $75.2
Bought 32 shares @ $2.51, valued at $80.3
Bought 32 shares @ $2.59, valued at $82.9
Bought 32 shares @ $2.59, valued at $82.9
Bought 32 shares @ $2.62, valued at $83.8
Bought 32 shares @ $2.55, valued at $81.6
Bought 34 shares @ $2.44, valued at $83
Bought 34 shares @ $2.38, valued at $80.9
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2022 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Bought 21 shares @ $4.14, valued at $86.9
Bought 21 shares @ $3.84, valued at $80.6
Bought 21 shares @ $4.47, valued at $93.9
Bought 21 shares @ $4.46, valued at $93.7
Bought 21 shares @ $5.61, valued at $117.8
Bought 21 shares @ $6.15, valued at $129.2
Bought 21 shares @ $5.81, valued at $122
Bought 21 shares @ $4.82, valued at $101.2
Bought 30 shares @ $4.36, valued at $130.8
Bought 30 shares @ $4.28, valued at $128.4
Bought 30 shares @ $4.29, valued at $128.7
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/05/2021 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Bought 42 shares @ $2.69, valued at $113
Bought 42 shares @ $2.87, valued at $120.5
Bought 42 shares @ $2.82, valued at $118.4
Bought 42 shares @ $2.76, valued at $115.9
Bought 42 shares @ $2.76, valued at $115.9
Bought 42 shares @ $2.84, valued at $119.3
Bought 42 shares @ $2.73, valued at $114.7
Bought 42 shares @ $2.71, valued at $113.8
Bought 42 shares @ $2.71, valued at $113.8
Bought 42 shares @ $2.81, valued at $118
Bought 42 shares @ $2.76, valued at $115.9
10/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/17/2020 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $3.56, valued at $3.6k
03/22/2019 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $5.98, valued at $6k
03/23/2018 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $6.7, valued at $6.7k
04/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/27/2013 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $4.78, valued at $4.8k
03/19/2012 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $7.72, valued at $7.7k
03/25/2011 4 Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC
Txns: Granted 1,000 shares @ $0
06/02/2010 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy